Vaxxinity

Vaxxinity

Biotechnology, 101 Ygnacio Vly Rd, Cape Canaveral, Florida, 94596, United States, 51-200 Employees

vaxxinity.com

  • facebook
  • twitter
  • instagram
  • LinkedIn

phone no Phone Number: 80********

Who is VAXXINITY

Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin ...

Read More

map
  • 101 Ygnacio Vly Rd, Cape Canaveral, Florida, 94596, United States Headquarters: 101 Ygnacio Vly Rd, Cape Canaveral, Florida, 94596, United States
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $250 Million to $500 Million

industries-icon Industry: Biotechnology

SIC SIC Code: 8111 | NAICS Code: 541110 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from VAXXINITY

Vaxxinity Org Chart and Mapping

Employees

Shuang Ding

Director, Bioassay & Biomarker

Tracy Kemp

VP, Clinical Development Operations

Ulo Palm

Chief Medical Officer

Erin Gilbert

Sr. Director, Manufacturing and Supply Chain

Kyle Merhi

IT Systems Administrator

Alana Wriggins

Head, Global Site Management Operations

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Vaxxinity

Answer: Vaxxinity's headquarters are located at 101 Ygnacio Vly Rd, Cape Canaveral, Florida, 94596, United States

Answer: Vaxxinity's phone number is 80********

Answer: Vaxxinity's official website is https://vaxxinity.com

Answer: Vaxxinity's revenue is $250 Million to $500 Million

Answer: Vaxxinity's SIC: 8111

Answer: Vaxxinity's NAICS: 541110

Answer: Vaxxinity has 51-200 employees

Answer: Vaxxinity is in Biotechnology

Answer: Vaxxinity contact info: Phone number: 80******** Website: https://vaxxinity.com

Answer: Vaxxinity is a U.S.-based global biotechnology company pioneering a new class of medicines to democratize health. Headquartered in Dallas, TX, with operations in the United States, Latin America, Europe and Asia, the companys proprietary technology platform has enabled the innovation of synthetic peptide vaccines designed to prevent or treat infectious diseases, including COVID-19, and chronic diseases, including Alzheimer's, Parkinsons, migraine, and hypercholesterolemia.. Vaxxinity has optimized its pipeline to achieve a potentially historic, global impact on human health. The key to the platform is the proprietary library of UBITh peptides, which are immunosilent, avoiding inflammation, and when linked to custom-designed target antigens, can elicit highly specific antibodies.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access